OpenFilings
PharmaCyte Biotech, Inc.
Form
8-K
Report Period
2025-09-02
Date Filed
2025-09-05
Time Filed
16:05:55
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 2, 2025
FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES H CONVERTIBLE PREFERRED STOCK OF T
FORM OF WARRANT OF TNF PHARMACEUTICALS, INC
REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 2, 2025
PRESS RELEASE DATED SEPTEMBER 2, 2025
Filing on SEC Edgar